ZYME Ratios (2021-2025) | ZYME

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter) -470.23%4.37%
EBIT Margin (Quarter) -536.08%-1.38%
EBITDA Margin (Quarter) -473.33%4.89%
Operating Margin (Quarter) -536.08%-1.38%
Net Margin (Quarter) -471.08%4.76%
FCF Margin (Quarter) -560.26%100.62%-1,857.27%1,253.20%-319.83%-112.52%23.86%
Efficiency
Assets Average (Quarter) 474.49M624.73M601.40M579.21M568.62M567.32M534.69M501.39M475.12M444.31M416.95M402.83M
Equity Average (Quarter) 265.77M252.36M201.02M336.36M483.25M461.23M436.63M444.57M451.40M422.08M386.57M352.87M331.87M329.74M327.29M
Invested Capital (Quarter) 249.09M282.44M222.28M179.76M492.96M473.54M448.92M424.34M464.81M438.00M406.16M366.98M338.77M324.97M334.51M320.06M
Asset Utilization Ratio (Quarter) 0.680.530.550.570.010.000.020.020.020.020.120.13
Leverage & Solvency
Equity Ratio (Quarter) 0.640.600.760.790.750.760.800.790.790.750.730.760.820.81
Valuation
Enterprise Value (Quarter) -252.61M-166.24M-492.23M-340.79M-340.09M-295.41M-374.33M-345.05M-330.15M-297.20M-225.78M-265.29M-281.38M-251.93M
Return Ratios
Return on Sales (Quarter) -4.71%-4.19%-4.71%-3.40%0.05%0.04%0.04%
Return on Assets (Quarter) -0.07%-0.08%-0.08%-0.08%0.01%0.01%
Return on Equity (Quarter) -0.09%-0.10%-0.11%-0.11%0.01%0.01%